For companies in the life sciences industry, medical communications is a core pillar for sharing clinical trial updates and connecting with peers. Because these materials require strict accuracy and academic rigor, biopharma companies have historically relied on specialized external agencies. This traditional approach guarantees expert messaging but often results in slow turnaround times and high costs that limit the number of projects a company can pursue.
While artificial intelligence has accelerated content creation across many sectors, the lack of reliable accuracy has prevented it from becoming a trusted tool in life sciences. Now, a communications platform trusted by 45 of the world’s top 50 biopharma organizations is looking to change the industry standard. Prezent Vivo has officially launched its reimagined AI-native platform, Prezent Vivo 1.0, designed to balance speed, cost and accuracy without losing human accountability.
The core of the new release is an interactive content studio that merges conversational AI with seamless access to over 25 enterprise data sources, including PubMed, Veeva and Microsoft Copilot. As teams experiment with drafts, an AI agent named Astrid works in the background to ensure that regulatory language, clinical evidence structures and brand compliance are embedded from the very beginning.
This self-serve environment empowers medical affairs and commercial teams to work more independently. A prime example of this capability is the generation of scientific posters for industry conferences. Astrid can process abstracts, publications and spreadsheets to produce congress-ready, publication-quality visuals in a matter of minutes.
A new business model to challenge traditional agencies
Recognizing that software alone cannot replace human expertise for complex projects, the startup has introduced a hybrid service model. Prezent Vivo 1.0 now features fixed-price projects, a fully managed offering that delivers agency-quality communications in 24 to 72 hours. By combining automated speed with expert scientific oversight, this service reduces costs by more than 50 percent compared to standard agency models.
These managed projects cover key industry needs such as competitive intelligence 360, advisory board insights and fast poster delivery. For higher stakes initiatives that require meticulous attention, the company also offers overnight editorial services supported by dedicated subject matter experts.
Prezent Vivo president Francine Carrick explained that the platform gives teams the flexibility to choose how they work, whether relying entirely on AI, using human experts or blending both to cut costs without losing scientific quality. Ultimately, the integration of automation and human accountability aims to help life sciences teams move faster from initial discovery to improved patient outcomes.
